Director DeVore purchases 1,200 shares of ELV for $374.6K, raising holdings 52.1% to 3.5K shares
Susan D. DeVore, a director at Elevance Health, acquired 1,200 shares at $312.15 on 2025-08-19, increasing her post-transaction holdings to 3,502 shares from 2,302 shares—a 52.1% increase in her personal stake. The stock is currently trading at $309.60, below the transaction price and -44.9% from its 52-week high of $562.29, though it has recovered +9.9% over the past 30 days. With Elevance trading at a 13.01 P/E ratio and generating $1.7B in net income on $49.8B in quarterly revenue, the company represents a large-cap health insurance player. The director's substantial proportional increase in holdings occurred during a period of stock weakness relative to recent highs, warranting attention to whether this reflects conviction in valuation or represents a scheduled transaction unrelated to near-term price outlook.